MMP2 and breast carcinoma: In contrast, expression of a SUMO E3 ligase inactive mutant of PIAS1, owing to replacement of Cysteine 350 with serine (PIAS1 (CS)), enhanced TGFβ-induced activation of MMP2 in MDA-MB-231 breast cancer cells (Figure 1A) [18, 26].